Literature DB >> 30702751

Inflammatory mechanisms in neurodegeneration.

Michael R Nichols1, Marie-Kim St-Pierre2,3, Ann-Christin Wendeln4,5, Nyasha J Makoni1, Lisa K Gouwens1, Evan C Garrad1, Mona Sohrabi6, Jonas J Neher4,5, Marie-Eve Tremblay2,3, Colin K Combs6.   

Abstract

This review discusses the profound connection between microglia, neuroinflammation, and Alzheimer's disease (AD). Theories have been postulated, tested, and modified over several decades. The findings have further bolstered the belief that microglia-mediated inflammation is both a product and contributor to AD pathology and progression. Distinct microglia phenotypes and their function, microglial recognition and response to protein aggregates in AD, and the overall role of microglia in AD are areas that have received considerable research attention and yielded significant results. The following article provides a historical perspective of microglia, a detailed discussion of multiple microglia phenotypes including dark microglia, and a review of a number of areas where microglia intersect with AD and other pathological neurological processes. The overall breadth of important discoveries achieved in these areas significantly strengthens the hypothesis that neuroinflammation plays a key role in AD. Future determination of the exact mechanisms by which microglia respond to, and attempt to mitigate, protein aggregation in AD may lead to new therapeutic strategies.
© 2019 International Society for Neurochemistry.

Entities:  

Keywords:  Alzheimer's disease; amyloid-beta; microglia; neuroinflammation

Mesh:

Year:  2019        PMID: 30702751      PMCID: PMC6541515          DOI: 10.1111/jnc.14674

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  226 in total

1.  Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain.

Authors:  F Alliot; I Godin; B Pessac
Journal:  Brain Res Dev Brain Res       Date:  1999-11-18

2.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

3.  Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.

Authors:  J D Harper; S S Wong; C M Lieber; P T Lansbury
Journal:  Biochemistry       Date:  1999-07-13       Impact factor: 3.162

4.  A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

Authors:  P S Aisen; K L Davis; J D Berg; K Schafer; K Campbell; R G Thomas; M F Weiner; M R Farlow; M Sano; M Grundman; L J Thal
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

Review 5.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

6.  Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells.

Authors:  H Chung; M I Brazil; T T Soe; F R Maxfield
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

7.  beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.

Authors:  C K Combs; J C Karlo; S C Kao; G E Landreth
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

8.  A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

Authors:  S Scharf; A Mander; A Ugoni; F Vajda; N Christophidis
Journal:  Neurology       Date:  1999-07-13       Impact factor: 9.910

9.  Anti-inflammatory drugs protect against Alzheimer disease at low doses.

Authors:  G A Broe; D A Grayson; H M Creasey; L M Waite; B J Casey; H P Bennett; W S Brooks; G M Halliday
Journal:  Arch Neurol       Date:  2000-11

10.  Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia.

Authors:  S L Yates; L H Burgess; J Kocsis-Angle; J M Antal; M D Dority; P B Embury; A M Piotrkowski; K R Brunden
Journal:  J Neurochem       Date:  2000-03       Impact factor: 5.372

View more
  30 in total

1.  Mindfulness, Education, and Exercise for age-related cognitive decline: Study protocol, pilot study results, and description of the baseline sample.

Authors:  Julie Loebach Wetherell; Hayley S Ripperger; Michelle Voegtle; Beau M Ances; David Balota; Emily S Bower; Colin Depp; Lisa Eyler; Erin R Foster; Denise Head; Tamara Hershey; Steven Hickman; Noralinda Kamantigue; Samuel Klein; J Philip Miller; Michael D Yingling; Jeanne Nichols; Ginger E Nicol; Bruce W Patterson; Thomas L Rodebaugh; Joshua S Shimony; Abraham Snyder; Mary Stephens; Susan Tate; Mary L Uhrich; David Wing; Gregory F Wu; Eric J Lenze
Journal:  Clin Trials       Date:  2020-06-27       Impact factor: 2.486

2.  Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the AppNL-G-F Mouse Model of Alzheimer's Disease.

Authors:  Mona Sohrabi; Heidi L Pecoraro; Colin K Combs
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  Nrf2 Suppresses Oxidative Stress and Inflammation in App Knock-In Alzheimer's Disease Model Mice.

Authors:  Akira Uruno; Daisuke Matsumaru; Rie Ryoke; Ritsumi Saito; Shiori Kadoguchi; Daisuke Saigusa; Takashi Saito; Takaomi C Saido; Ryuta Kawashima; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2020-02-27       Impact factor: 4.272

4.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

5.  Novel Somatostatin Receptor-4 Agonist SM-I-26 Mitigates Lipopolysaccharide-Induced Inflammatory Gene Expression in Microglia.

Authors:  Ashok Silwal; Austin House; Karin Sandoval; Shaluah Vijeth; David Umbaugh; Albert Crider; Shirin Mobayen; William Neumann; Ken A Witt
Journal:  Neurochem Res       Date:  2021-11-30       Impact factor: 3.996

6.  Enhanced M-CSF/CSF1R Signaling Closely Associates with PrPSc Accumulation in the Scrapie-Infected Cell Line and the Brains of Scrapie-Infected Experimental Rodents.

Authors:  Ying Xia; Cao Chen; Jia Chen; Chao Hu; Wei Yang; Lin Wang; Lian Liu; Li-Ping Gao; Yue-Zhang Wu; Dong-Dong Chen; Qi Shi; Zhi-Bao Chen; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2022-08-15       Impact factor: 5.682

7.  Effect of tricyclic 1,2-thiazine derivatives in neuroinflammation induced by preincubation with lipopolysaccharide or coculturing with microglia-like cells.

Authors:  Benita Wiatrak; Edward Krzyżak; Berenika Szczęśniak-Sięga; Marta Szandruk-Bender; Adam Szeląg; Beata Nowak
Journal:  Pharmacol Rep       Date:  2022-09-21       Impact factor: 3.919

Review 8.  The role of triggering receptor expressed on myeloid cells-1 (TREM-1) in central nervous system diseases.

Authors:  Chunyan Zhang; Xugang Kan; Baole Zhang; Haibo Ni; Jianfeng Shao
Journal:  Mol Brain       Date:  2022-10-22       Impact factor: 4.399

9.  Differential Diagnosis of Chorea-HIV Infection Delays Diagnosis of Huntington's Disease by Years.

Authors:  Jannis Achenbach; Simon Faissner; Carsten Saft
Journal:  Brain Sci       Date:  2021-05-27

10.  Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease.

Authors:  Jeffrey Cummings
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2020-10-28       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.